Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, no par value per share
-
Shares outstanding
-
112,245,592
-
Total 13F shares
-
84,791,322
-
Share change
-
-143,501
-
Total reported value
-
$6,218,802,349
-
Put/Call ratio
-
158%
-
Price per share
-
$73.35
-
Number of holders
-
292
-
Value change
-
-$14,733,916
-
Number of buys
-
129
-
Number of sells
-
125
Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q4 2022
As of 31 Dec 2022,
NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,791,322 shares.
The largest 10 holders included
FMR LLC, Capital World Investors, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, Capital International Investors, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Nordwand Advisors, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
292
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.